Injection Molding and its application to drug delivery

Journal of Controlled Release

Volumn 159, Issue 3, 2012, Pages 324-331

  Zema, Lucia ^a   Loreti, Giulia ^a   Melocchi, Alice ^a   Maroni, Alessandra ^a   Gazzaniga, Andrea ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Continuous manufacturing; Controlled release; Dosage forms; Injection molding; Microinjection molding; Thermoplastic polymer

Indexed keywords

ACTIVE INGREDIENTS; CONTROLLED RELEASE; DOSAGE FORMS; HIGH-PRESSURE CONDITION; INNOVATIVE SYSTEMS; MANUFACTURING STRATEGY; MICRO-INJECTION MOLDING; MOLD CAVITIES; MOLECULAR DISPERSIONS; PATENTABILITY; PERFORMANCE CHARACTERISTICS; PHARMACEUTICAL APPLICATIONS; PROCESS STEPS; PRODUCTION COST; THERMOPLASTIC POLYMER;

DRUG DELIVERY; HIGH PRESSURE ENGINEERING; MANUFACTURE; PLASTICS INDUSTRY; PRODUCT DESIGN;

INJECTION MOLDING;

EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 6000; POLYLACTIC ACID; SOLVENT; WATER;

CONTROLLED RELEASE FORMULATION; COST; DISPERSION; DRUG DECOMPOSITION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG MANUFACTURE; HEAT; HUMAN; HYPERBARISM; INJECTION MOLDING; MEDICAL TECHNOLOGIST; NONHUMAN; PATENT; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS;

ANIMALS; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HOT TEMPERATURE; HUMANS; PHASE TRANSITION; POLYMERS;

EID: 84860665285     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.01.001     Document Type: Review

References (80)

1. D.M. Bryce Plastic injection molding... manufacturing process fundamentals vol. 1 1996 Society of Manufacturing Engineers Michigan
2. M.R. Kamal, A.I. Isayev, and S.-J. Liu Injection Molding: Technology and Fundamentals 2009 Hanser Ohio
3. D.V. Rosato, D.V. Rosato, and M.G. Rosato Injection Molding Handbook third ed. 2000 Kluwer Academic Massachussets
4. T.A. Osswald Injection molding materials T.A. Osswald, L.-S. Turng, P.J. Gramann, Injection molding Handbook second ed 2008 Hanser Ohio 19 61
5. M.E. Gomes, A.S. Ribeiro, P.B. Malafaya, R.L. Reis, and A.M. Cunha A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour Biomaterials 22 9 2011 883 889
6. H. Haugen, J. Will, W. Fuchs, and E. Wintermantel A novel processing method for injection-molded polyether-urethane scaffolds, Part 1: Processing J. Biomed. Mater. Res. Part B 77 1 2006 65 72
7. F. Sammoura, J. Kang, Y.-M. Heo, T. Jung, and L. Lin Polymeric microneedle fabrication using a microinjection molding technique Microsyst. Technol. 13 5-6 2007 517 522
8. S. Ghosh, J.C. Viana, R.L. Reis, and J.F. Mano Development of porous lamellar poly(l-lactic acid) scaffolds by conventional injection molding process Acta Biomater. 4 4 2008 887 896
9. A. Kramschuster, and L.-S. Turng An Injection Molding process for manufacturing highly porous and interconnected biodegradable polymer matrices for use as tissue engineering scaffolds J. Biomed. Mater. Res. B Appl. Biomater. 92B 2 2009 366 376
10. Y. Zhang, K. Brown, K. Siebenaler, A. Determan, D. Dohmeier, and K. Hansen Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action Pharm. Res. 29 1 2012 170 177
11. R. Hoyle Manufacturing components for a micro litre drug delivery system Eur. Med. Device Technol. 1 4 2010
12. P. Speiser, Injection-moulded oral medicament in solid form, US Patent 3,432,592 (1969).
13. R.F.T. Stepto, and I. Tomka Injection moulding of natural hydrophilic polymers in the presence of water Chimia 41 3 1987 76 81
14. G. Cuff, and F. Raouf A preliminary evaluation of injection moulding as a tabletting technology Pharm. Technol. Eur. 11 4 1999 18 26
15. L.C. Li, J. Deng, and D. Stephens Polyanhydride implant for antibiotic delivery - from the bench to the clinic Adv. Drug Deliv. Rev. 54 7 2002 963 986
16. L. Eith, R.F.T. Stepto, I. Tomka, and F. Wittwer The injection-moulded capsule Drug Dev. Ind. Pharm. 12 11-13 1986 2113 2126
17. J.-S. Deng, M. Meisters, L. Li, J. Setesak, L. Claycomb, Y. Tian, D. Stephens, and M. Widman The development of an injection-molding process for a polyanhydride implant containing gentamicin sulfate PDA J. Pharm. Sci. Technol. 56 2 2002 65 77
18. M. Heckele, and W.K. Schomburg Review on micro molding of thermoplastic polymers J. Micromech. Microeng. 14 2004 R1 R14
19. L. Eith, R.F.T. Stepto, and I. Tomka Injection-moulded drug-delivery systems Manuf. Chem. 58 1 1987 21 25
20. S. Wacker, M. Soliva, and P. Speiser Injection molding as a suitable process for manufacturing solid dispersions or solutions Pharm. Ind. 53 9 1991 853 856
21. C. König, K. Ruffieux, E. Wintermantel, and J. Blaser Autosterilization of biodegradable implants by injection molding process J. Biomed. Mater. Res. 38 2 1997 115 119
22. M.M. Crowley, M.A. Repka, S. Thumma, S.B. Upadhye, and S. Kumar Battu Pharmaceutical applications of hot-melt extrusion: part I Drug Dev. Ind. Pharm. 33 9 2007 909 927
23. M.A. Repka, S. Majumadar, S. Kumar Battu, R. Srirangam, and S.B. Upadhye Application of hot-melt extrusion for drug delivery Expert Opin. Drug Deliv. 5 12 2008 1357 1376
24. J.M. Fischer Handbook of molded part shrinkage and warpage 2003 William Andrew Inc. New York
25. B.R. Whiteside, M.T. Martyn, and P.D. Coates Introduction to micromolding J. Greener, R. Wimberger-Friedl, Precision injection molding: process, materials, and applications 2006 Hanser Ohio 239 264
26. J. Giboz, T. Copponnex, and P. Mèle Microinjection molding of thermoplastic polymers: a review J. Micromech. Microeng. 17 2007 R96 R109
27. M. Koç, and T. Özel Micro-injection molding M. Koç, T. Özel, Micro-manufacturing: design and manufacturing of micro-products 2011 John Wiley & Sons New Jersey 106 109
28. C.M. Vaz, P.F.N.M. van Doeveren, R.L. Reis, and A.M. Chunha Development and design of double-layer co-injection moulded soy protein based drug delivery devices Polymer 44 19 2003 5983 5992
29. T. Quinten, T. De Beer, C. Vervaet, and J.P. Remon Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets Eur. J. Pharm. Biopharm. 71 1 2009 145 154
30. T. Quinten, Y. Gonnissenn, E. Adriaens, T. De Beer, V. Cnudde, B. Masschaele, L. Van Hoorebeke, J. Siepmann, J.P. Remon, and C. Vervaet Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose Eur. J. Pharm. Sci. 37 3-4 2009 207 216
31. T. Quinten, T. De Beer, A. Almeida, J. Vlassenbroeck, L. Van Hoorebeke, J.P. Remon, and C. Vervaet Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide Drug Dev. Ind. Pharm. 37 2 2011 149 159
32. T. Quinten, T. De Beer, F.O. Onofre, G. Mendez-Montealvo, Y.J. Wang, J.P. Remon, and C. Vervaet Sustained-release and swelling characteristics of xantan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation J. Pharm. Sci. 100 7 2011 2858 2870
33. A. Gazzaniga, M. Cerea, A. Cozzi, A. Foppoli, A. Maroni, and L. Zema A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers AAPS PharmSciTech 12 1 2011 295 303
34. R.F.T. Stepto Thermoplastic starch and drug delivery capsules Polym. Int. 43 2 1997 155 158
35. L. Kuutti, J. Peltonen, P. Myllärinen, O. Teleman, and P. Forssell AFM in studies of thermoplastic starches during ageing Carbohydr. Polym. 37 1 1998 7 12
36. R.F.T. Stepto Understanding the processing of thermoplastic starch Macromol. Symp. 245-246 1 2006 571 577
37. T. Czigány, G. Romhány, and J.G. Kovács Starch for injection molding purposes S. Fakirov, D. Bhattacharyya, Handbook of engineering biopolymers: homopolymers, blends and composites 2007 Hanser Ohio 81 108
38. T. Tábi, and J.G. Kovács Examination of injection moulded thermoplastic maize starch Express Polym. Lett. 1 12 2007 804 809
39. C.J. Kenyon, E.T. Cole, and I. Wilding The effect of food on the in vivo behaviour of enteric coated starch capsules Int. J. Pharm. 112 1994 207 213
40. S. Idrissi, R. Dumesnil, L. Michel, and M. Traisnel Capill: substitution of gelatin by starch Pharm. Acta Helv. 66 9-10 1991 246 252
41. S.J. Burns, D. Corness, G. Hay, S. Higginbottom, I. Whelan, D. Attwood, and S.G. Barnwell An in vitro assessment of liquid-filled Capill® potato starch capsules with biphasic release characteristics Int. J. Pharm. 134 1-2 1996 223 230
42. B. Brogmann, and K. Lehmann Stability of enteric gelatin and starch capsules coated with aqueous dispersions of methacrylic acid copolymers Pharm. Res. 11 1994 S 167
43. P. Watts Colonic drug delivery composition 1995 WO9535100A1
44. V.D. Vilivalam, L. Illum, and K. Iqbal Starch capsules: an alternative system for oral drug delivery Pharm. Sci. Technol. Today 3 2 2000 64 69
45. A. Gazzaniga, F. Giordano, M.E. Sangalli, and L. Zema Oral colon-specific drug delivery: Design strategies S.T.P. Pharma Pratiques 4 5 1994 336 343
46. A. Gazzaniga, A. Maroni, M.E. Sangalli, and L. Zema Time-controlled oral delivery systems for colon targeting Expert Opin. Drug Deliv. 3 5 2006 583 597
47. S. Keszei, A. Szabó, G. Marosi, P. Anna, and S. Nagy Use of thermoplastic starch in continuous pharmaceutical process Macromol. Symp. 239 1 2006 101 104
48. A. Rothen-Weinhold, K. Besseghir, E. Vuaridel, E. Sublet, N. Oudry, F. Kubel, and R. Gurny Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants Eur. J. Pharm. Biopharm. 48 2 1999 113 121
49. I. Soriano, A.Y. Martín, C. Évora, and E. Sánchez Biodegradable implantable fluconazole delivery rods designed for the treatment of fungal osteomyelitis: influence of gamma sterilization J. Biomed. Mater. Res. A 77 3 2006 632 638
50. L. Cheng, S. Guo, and W. Wu Characterization and in vitro release of praziquantel from poly(ε-caprolactone) implants Int. J. Pharm. 377 1-2 2009 112 119
51. S.A.H. Hanafy, A.M. El-Egaky, S.A.M. Mortada, and A.M. Molokhia Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers Drug Discov. Ther. 3 6 2009 287 295
52. A. Gokhale, J. McConnell, A. Loxley, and M. Mitchnick Combination devices to protect women from sexual transmission of HIV Drug Deliv. Technol. 9 3 2009 18 21
53. M.J. Rathbone, C.R. Bunt, C.R. Ogle, S. Burggraaf, K.L. Macmillan, and K. Pickering Development of an injection molded poly(ε-caprolcatone) intravaginal insert for the delivery of progesterone to cattle J. Control. Release 85 1-3 2002 61 71
54. D. Bar-Shalom, L. Slot, W. Wang Lee, C.G. Wilson, Development of the Egalet® technology in: M.J. Rathbone, J. Hadgraft, M. S. Roberts (Eds.), Modified-release drug delivery technology Marcel Dekker, New York, 2003, pp. 263-271.
55. A.V. Pedersen, and P.H. Hemmingsen Erosion-based drug delivery Manuf. Chem. November 2006 1 6
56. N. Washington, and C.G. Wilson Erosion versus diffusion - The future for controlled and sustained drug delivery Drug Deliv. Technol. 6 9 2006 71 74
57. N. Washington, and C.G. Wilson Can oral controlled drug delivery meet the challenges posed by chronotherapeutics? Int. J. Pharm. 6 6 2006 57 59
58. D. Bar-Shalom, C.G. Wilson, and N. Washington Cronotherapy using Egalet® technology B.-B.C. Youan, Chronopharmaceutics 2009 John Wiley & Sons New Jersey 165 173
59. http://www.egalet.com/index.dsp?area=7, accessed on 10/06/2011.
60. J. Marvola, H. Kanerva, L. Slot, M. Lipponen, T. Kekki, H. Hietanen, S. Mykkänen, K. Ariniemi, K. Lindevall, and M. Marvola Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet® constant-release drug delivery system Int. J. Pharm. 281 1-2 2004 3 10
61. D. Ridgway, M. Sopata, A. Burkneckis, L. Jespersen, and C. Andersen Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice daily dosing of a standard controlled-release morphine tablet in patients whit cancer pain: a randomized, double-blind, exploratory crossover study J. Pain Symptom Manage. 39 4 2010 712 720
62. P.H. Hemmingsen, A.-M. Haar, C. Gunnergaard, and J.-M. Cardot Development of a new type of prolonged release hydrocodone formulation based on Egalet® ADPREM technology using in vivo-in vitro correlation Pharmaceutics 3 1 2011 73 87
63. www.egalet.com/index.dsp?area=32, accessed on 10/06/2011.
64. C.M. Vaz, P.F.N.M. van Doeveren, R.L. Reis, and A.M. Chunha Soy matrix drug delivery systems obtained by melt-processing techniques Biomacromolecules 4 6 2003 1520 1529
65. C.M. Vaz, P.F.N.M. van Doeveren, G.R. Dias, R.L. Reis, and A.M. Chunha Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding Macromol. Biosci. 4 8 2004 795 801
66. J. Avery, Injection molding alternatives a guide for designers and product engineers, Hanser (Ed.), Germany, 1998, pp.102-112.
67. A. Gazzaniga, M.E. Sangalli, and F. Giordano Oral Chronotopic® drug delivery systems: Achievement of time and/or site specificity Eur. J. Pharm. Biopharm. 40 3 1994 246 250
68. M.E. Sangalli, A. Maroni, L. Zema, C. Busetti, F. Giordano, and A. Gazzaniga In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery J. Control. Release 73 1 2001 103 110
69. M.E. Sangalli, A. Maroni, A. Foppoli, L. Zema, F. Giordano, and A. Gazzaniga Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performance Eur. J. Pharm. Sci. 22 5 2004 469 476
70. L. Zema, A. Maroni, A. Foppoli, L. Palugan, M.E. Sangalli, and A. Gazzaniga Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: An investigation into the mechanisms governing drug release J. Pharm. Sci. 96 6 2007 1527 1536
71. M.E. Sangalli, A. Maroni, L. Zema, M. Cerea, and A. Gazzaniga Chronotopic™ Technology B.-B.C. Youan, Chronopharmaceutics 2009 John Wiley & Sons New Jersey 145 163
72. A. Gazzaniga, A. Foppoli, A. Maroni, A. Cozzi, E. Macchi, and M. Cerea Injection-molded capsular device for oral pulsatile delivery: an in vivo evaluation CRS annual meeting 2011
73. R. Gröning, E. Kuhlmann, and R.S. Müller Biodegradation of high-tech drug delivery systems Pharm. Ind. 70 11 2008 1409 1413
74. R. Gröning, and M. Berntgen Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule Pharmazie 51 5 1991 328 331
75. J. Fujimori, Y. Machida, and T. Nagai Preparation of a magnetically-responsive tablet and confirmation of its gastric residence in beagle dogs S.T.P. Pharm. Sci. 4 1994 425 430
76. R. Gröning, M. Berntgen, and M. Georgarakis Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit Int. J. Pharm. Biopharm. 46 3 1998 285 291
77. R. Gröning Computer-controlled drug release form small-sized dosage forms J. Control. Release 48 2-3 1997 185 193
78. J.T. Santini, A.C. Richards, R. Scheidt, M.J. Cima, and R. Langer Microchips as controlled drug-delivery devices Angew. Chem. Int. 39 14 2000 2396 2407
79. R.S. Shawgo, A.C. Richards Grayson, Y. Li, and M.J. Cima BioMEMS for drug delivery Curr. Opin. Solid State Mater. Sci. 6 4 2002 329 334
80. R. Pal Singh, N. Sarju, A. Sharma, S. Gupta Singh, and K. Sanket Microchip for drug delivery system: a review J. Appl. Pharm. Sci. 1 4 2011 7 11